EUVIMEDEUVIMED entdecken
Crossref

The sRNA-encoded peptide TimP rewires the Escherichia coli envelope via LamB to sensitize bacteria to polymyxins

Hyejin Cho, Juyeon Jung, Soyeon Yi, Kwang-Sun Kim

Drug Resistance Updates · 2026

DOI: 10.1016/j.drup.2026.101406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Resistance Updates, 2026. Verfasst von Hyejin Cho und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: Escherichia coli, Anti-Bacterial Agents, Polymyxins, Porins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 99 Literaturangaben. Gefördert von: National Research Foundation of Korea, National Institute of Genetics, Ministry of Science and ICT, South Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rise of multidrug-resistant (MDR) Escherichia coli has marginalized last-line polymyxins (PMs) owing to evolving resistance and narrow therapeutic windows. Revitalizing these agents requires the identification of novel regulatory circuits governing the integrity of the gram-negative envelope. In this study, we identified a stress-responsive peptide TimP and demonstrated that its intracellular overexpression (TimP+), a synthetic variant (FT-Pep), and biogenic TimP+-derived extracellular vesicles (TimP EVs) exhibited equivalent functionality in sensitizing E. coli to PMs, consistently inducing PM-mediated phenotypes. Mechanistically, TimP in E. coli initiates coordinated envelope remodeling by interacting with porin LamB via a specific N21TimP-R134LamB molecular interface. Furthermore, the TimP-TimR/TimP-LamB interaction is functionally conserved in both E. coli and Salmonella. Pharmacokinetic profiling and spatiotemporal imaging of FT-Pep revealed a predictable physiological disposition across major organs and gradual systemic clearance over 24 h, with no evidence of pathological sequestration. Hepatic and immunological assessments confirmed that FT-Pep or TimP EVs were systemically inert, with serum pro-inflammatory markers and liver enzymes remaining within baseline physiological ranges. Exploiting these beneficial effects, we engineered polymyxin B (PMB)@TimP EVs, which exhibited enhanced bactericidal activity, improved pH stability, and negligible mammalian cytotoxicity compared with free PMB. In a murine sepsis model, PMB@TimP EVs demonstrated clear in vivo efficacy at an equivalent dose, maintaining survival when free PMB failed. Collectively, this study identified TimP as a conserved target and demonstrated a Trojan-horse drug delivery system capable of restoring the efficacy of PM against MDR gram-negative pathogens.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Escherichia coliAnti-Bacterial AgentsPolymyxinsPorinsEscherichia coli ProteinsBacterial Outer Membrane ProteinsPeptidesAnimalsMiceEscherichia coli InfectionsDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsExtracellular VesiclesHumans

Stichwörter der Autor:innen

Drug delivery systemExtracellular vesiclesLamB porinPolymyxin sensitizationTimP

Substanzen

Anti-Bacterial AgentsPolymyxinsPorinsEscherichia coli ProteinsBacterial Outer Membrane ProteinsPeptides

Autor:innen und Institutionen

  • Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Republic of Korea.
  • Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea; School of Pharmacy, Sungkyunkwan University (SKKU), Suwon…
  • Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.
  • Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 46241, Republic of Korea. Electronic address: kwangsun.kim@pusan.ac.kr.

Förderung

  • National Research Foundation of Korea
  • National Institute of Genetics
  • Ministry of Science and ICT, South Korea

Zitieren

APA

Cho, H., Jung, J., Yi, S., & Kim, K. S. (2026). The sRNA-encoded peptide TimP rewires the Escherichia coli envelope via LamB to sensitize bacteria to polymyxins. Drug Resistance Updates. https://doi.org/10.1016/j.drup.2026.101406

Vancouver

Cho H, Jung J, Yi S, Kim KS. The sRNA-encoded peptide TimP rewires the Escherichia coli envelope via LamB to sensitize bacteria to polymyxins. Drug Resistance Updates. 2026. doi:10.1016/j.drup.2026.101406

BibTeX
@article{Cho2026,
  author = {Cho, Hyejin and Jung, Juyeon and Yi, Soyeon and Kim, Kwang-Sun},
  title = {The sRNA-encoded peptide TimP rewires the Escherichia coli envelope via LamB to sensitize bacteria to polymyxins},
  journal = {Drug Resistance Updates},
  year = {2026},
  doi = {10.1016/j.drup.2026.101406}
}
Kostenlos starten →